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Abstract
Risk of developing inflammation-associated cancers has increased in industrialized countries 
during the past 30 years. One possible explanation is societal hygiene practices with use of 
antibiotics and Caesarian births that provide too few early life exposures of beneficial microbes. 
Building upon a ‘hygiene hypothesis’ model whereby prior microbial exposures lead to beneficial 
changes in CD4+ lymphocytes, here we use an adoptive cell transfer model and find that too few 
prior microbe exposures alternatively result in increased inflammation-associated cancer growth in 
susceptible recipient mice. Specifically, purified CD4+ lymphocytes collected from ‘restricted 
flora’ donors increases multiplicity and features of malignancy in intestinal polyps of recipient 
ApcMin/+ mice, coincident with increased inflammatory cell infiltrates and instability of the 
intestinal microbiota. We conclude that while a competent immune system serves to maintain 
intestinal homeostasis and good health, under hygienic rearing conditions CD4+ lymphocytes 
instead exacerbate inflammation-associated tumorigenesis, subsequently contributing to more 
frequent cancers in industrialized societies.
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Introduction
Routine environmental exposures to microbes and microbial products are increasingly 
understood to affect risk of chronic inflammatory diseases later in life(1-9). Microbial 
exposures are abundant in the natural environment, but are greatly reduced with hygienic 
practices and antibiotic usage that are widespread in modern lifestyles. Microbial exposures 
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represent important background stimulation for normal immune system development, such 
that limited microbe exposures in early life result in persistent overreaction to stimuli later in 
life (10). This concept that early-life microbial exposures and their connection with immune 
over-reactions later in life has been referred to as the “hygiene hypothesis” (10-16). In this 
‘hygiene’ model, too few exposures and insufficient CD4 cell priming leads to uncontrolled 
inflammatory responses and chronic inflammation. Immune over-reactions resulting in 
chronic inflammation have also been implicated in causation of cancers in the colon and 
other sites in humans (16).
Studies in lymphocyte-deficient mice using adoptive transfer techniques have shown that 
CD4+ lymphocytes significantly modulate inflammation in the lower bowel (17-22) and 
throughout the body (16, 23-26). While intact CD4+ cell populations protect from cancer 
and other pathology, prior studies using adoptive transfer of CD4+ lymphocytes in Rag-
deficient mouse models of inflammatory bowel disease (IBD) have dissected mechanisms 
involving gut microbiota and counter-regulation of inflammation. Such studies have 
revealed an interleukin-10 (IL-10)–dependent suppression of colitis-associated colon cancer 
(21, 27, 28). This showed explicitly that inhibition of enteric inflammation is pivotal in 
intestinal tumorigenesis (16, 21, 27, 28). We have previously tested roles for T cells using 
adoptive cell transfer in sporadic CRC in C57BL/6 mice heterozygous for a mutation in the 
Apc gene (ApcMin/+)(23, 28), which are genetically prone to intestinal polyps that mimic 
early stages of sporadic CRC in humans(29, 30). Although risk for sporadic colorectal 
cancer (CRC) is reduced by non-steroidal anti-inflammatory drug (NSAID) usage in 
humans, intestinal polyps without overt inflammation are less clearly associated with 
inflammation than is IBD-CRC. We now know, that despite a lack of overt inflammation, 
there were higher systemic levels of TNF-α, IL-6 and IL-17 in ApcMin/+ mice with intestinal 
polyposis (16) matching findings in colon cancer in humans (31). More recently, it has 
become clear from studies using other model systems that intestinal microbiota and 
inflammation are inextricably linked with risk of developing colon cancer (32-35).
Prior work in our laboratory(24, 36, 37) and others(38, 39) supports a model in which 
enteric infections early in life may ultimately suppress IBD and cancer by modulating T cell 
responses, consistent with the observations of the “hygiene hypothesis” by Belkaid and 
Rouse (11). Specifically, we showed that the beneficial cancer-suppressing effects of 
microbial infections are dependent on Interleukin (IL)-10 (27, 28, 36, 37) a cytokine that 
also provides suppressive and feedback inhibitory effects on allergies and autoimmune 
responses (12). Early life exposures to microbial products have been well studied regarding 
the etiologies of allergies and asthma. It follows that reduced or delayed exposures to 
microbiota or their products in childhood might hinder normal immune functions in adult 
life. Although the ‘hygiene hypothesis’ has been considered in depth for etiology of 
autoimmune diseases (10, 13), few studies other than our own (14-16, 24, 36, 37) have 
addressed these concepts as they may relate to cancer development in bowel or extra-
intestinal sites.
In humans, the risk of developing CRC is lower in countries that have less stringent hygiene 
practices (40, 41). To test this concept of whether this may be due to T cells that fail to 
protect from intestinal pathology, we applied a T cell transfer animal model using over-
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reactive “hygienic” lymphocytes in adenoma-prone ApcMin/+ model. CD4+ lymphocytes 
were isolated from restricted flora wild type (wt) C57BL/6 mice and then injected at dosage 
of 3×10^5 cells per mouse into mice with additional accumulated gut microbial diversity: 
co-housed littermate ApcMin/+ and wt recipient animals. We found that cells collected from 
the uninfected “hygienic” donor mice not only failed to provide protection against intestinal 
tumor development, but rather increased intestinal tumor burden commensurate with 
destabilizing changes in the host gut microbiome.
Results
ApcMin/+ mice are genetically at increased risk for intestinal polyps
In humans, the risk of developing CRC is lower in countries that have less stringent hygiene 
practices (40, 41). To test whether roles for lymphocytes in sporadic CRC, as they may 
conform to the aforementioned paradigm of autoimmunity, we examined C57BL/6 mice 
heterozygous for a mutation in the Apc gene (ApcMin/+), making these mice genetically 
prone to intestinal polyps that mimic early stages of sporadic CRC in humans (29, 30). Here 
we examined polyposis in 5-mos-old ApcMin/+ and wt littermate mice (Figure 1). Despite a 
lack of overt intestinal inflammation, ApcMin/+ mice are prone to intestinal polyposis 
matching important aspects of colon cancer in humans (31). This provides a framework to 
test in immunologically-intact animals whether ability of CD4+ T cells to suppress cancer 
may be more dependent on the prior microbial exposures of the lymphocyte donor rather 
than that of the recipient animals (16).
Gut microbiome is more divergent in ApcMin/+ mice than in co-housed wt littermates
It was previously shown that dysregulated inflammatory responses may destabilize the gut 
microbiome and contribute to colon cancer (32-35). To test the roles of ‘hygienic’ CD4+ 
cells in this putative destabilizing process, we first performed on mouse stool a microbiome 
analysis using high-throughput sequencing of the V4 region of the 16S gene using an 
Ilumina HiSeq platform. After quality filtering, we recovered an average of 26,879 reads per 
sample from 58 samples collected from 18 animals, including 12 harboring the ApcMin/+ 
mutation and 6 littermates with a wt genotype. We clustered these sequences into 1703 
operational taxonomic units for further analysis as previously described (42). We then 
compared the compositional variance of baseline sequence data collected from wildtype 
mice and among ApcMin/+ mice. Interestingly, we found that although the alpha diversity 
was not significantly different between these groups, the beta-diversity (or divergence 
within a group) was higher even in the unmanipulated ApcMin/+ group. Specifically, the 
average Jensen-Shannon Divergence (JSD) among ApcMin/+ mice (0.24) was higher than 
among co-housed WT littermates (0.18, p = 2.55 e-05, Mann-Whitney U-test). The ApcMin/+ 
microbiome is more variable across individuals, consistent with reduced regulation of the 
microbial population under the influence of the ApcMin/+ mutation (Fig. 2a). That this 
observation persists despite coprophagia among co-housed WT littermates that were reared 
together suggests that the ApcMin/+ mutation may play a role in regulating the composition 
of the microbiome, potentially mediated by cell-based immunity.
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Transfer of CD4+ lymphocytes collected from ‘hygienic’ restricted flora donor mice rapidly 
increases inflammatory cell infiltrates and intestinal tumorigenesis
In immune competent animals, whole CD4+ T cells potently suppress inflammation, and 
their ability to do so was previously shown to be more dependent on the prior microbial 
exposures of the lymphocyte donor rather than that of the recipient animals (16). To test this 
concept of whether T cells may fail to protect from intestinal pathology under more 
“hygienic” conditions in the adenoma-prone ApcMin/+ model, we applied a T cell transfer 
model. CD4+ lymphocytes were isolated from restricted flora source [hygienic] C57BL/6 
mice and then injected at dosage of 3X10^5 cells per mouse into littermate ApcMin/+ and wt 
littermate recipient animals. We found that cells collected from “hygienic” donor mice not 
only failed to provide protection against intestinal tumor development, but rather increased 
intestinal tumor burden in ApcMin/+ mice when compared with sham-dosed controls [Fig. 1].
Furthermore, the adenomatous polyps of mice that received “hygienic” lymphocytes were in 
a more advanced stage of the adenoma to adenocarcinoma progression compared to their 
sham-treated counterparts. Based on previously described histomorphological criteria (21, 
43, 44) focal lesions of dysplasia/adenoma within polyps were identified as low-grade 
dysplasia (LGD) or high-grade dysplasia (HGD) and carcinoma in situ (CIS, intraepithelial 
neoplasia) [Fig 3a]. The classification of small intestinal polyps according to the most 
advanced lesion they contained showed that “hygienic” T cell recipient mice had 
significantly more polyps bearing CIS compared to control mice [Fig 3b and 3c]. 
Lymphocytes, macrophages, neutrophils, plasmacytes and mast cells in the intestinal 
adenomas of both groups of ApcMin/+ mice followed the typical polyp-associated 
inflammatory cell topographical distribution pattern(23, 44). However, the inflammatory 
cell accumulation was more pronounced in the polyps of “hygienic” cell recipients. We have 
previously shown that neutrophils enhance intestinal tumorigenesis and that their 
accumulation in cancer-prone epithelia is influenced by CD4+ cell subsets(23, 44, 45). We 
next quantitatively assessed MPO+ granulocytes (neutrophils) in the polyps of ApcMin/+ 
mice. We found that tumor-associated MPO+ cells were significantly more in the mice 
treated with “hygienic” CD4+ lymphocytes when compared to the sham-dosed controls [Fig. 
4].
Gut microbiome is more divergent in ApcMin mice after adoptive transfer of ‘hygienic’ pro-
inflammatory CD4+ lymphocytes
Finally, to test whether the ‘hygienic’ + cells lead to increased microbial divergence that 
may contribute to cancer risk, we examined stool of cell transfer recipients of lymphocytes 
from syngeneic C57BL/6 wt cell donors of ultra-hygienic restricted flora health status into 
these ApcMin/+ or wt mice housed under conventional conditions. In the absence of this 
intervention, mice experienced modest ecological drift equivalent to a Jensen Shannon 
Divergence (JSD) of approximately 0.17 in both ApcMin/+ and their wt littermate mice. 
Wildtype mice subjected to lymphocyte transfer experienced a similar level of change in 
their microbiome (0.16, ns). However, ApcMin/+ mice subjected to lymphocyte transfer 
experienced a radical change in their microbiome of approximately double (0.31) the 
background rate of change in untreated controls (p = 0.05, Mann-Whitney U-test in Jensen-
Shannon Divergence between paired time points in each animal) (Fig. 2b). Operational 
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taxonomic unit (OTU)-level microbial events were found to be driving the higher level 
changes in diversity (Fig. 2c). The radical change in microbiome after transplant of 
‘hygienic’ lymphocytes coincided with increased gut inflammatory index (Fig. 4), and also 
features of intestinal adenoma multiplicity (Fig. 1) and malignancy (Fig. 3). This further 
implicates the immune system in the diversity of the ApcMin/+ microbiome and predilection 
to cancer.
Discussion
To test this concept of whether T cells arising under “hygienic” conditions may fail to 
protect from intestinal pathology, we applied a T cell transfer model in the adenoma-prone 
ApcMin/+ model. Under normal conditions, whole CD4+ T cells prevent intestinal pathology 
(16, 20). However, we found that cells collected from the restricted flora “hygienic” donor 
mice not only failed to provide protection against intestinal tumor development, but rather 
increased intestinal tumor burden. Adenomatous polyps of mice that received “hygienic” 
lymphocytes were in a more advanced stage of adenocarcinoma development, coincident 
with an increased inflammatory cell index within adenomas. Taken together, these 
observations connect the immune system, hygienic rearing, and diverse immune-mediated 
diseases including allergies, autoimmune disease, and cancer (16).
The radical change in microbiome after transplant of ‘hygienic’ lymphocytes coincided with 
an increased gut inflammatory index and intestinal adenoma multiplicity and malignancy, 
further implicating the immune system in the diversity of the ApcMin/+ microbiome and 
predilection to cancer. Indeed, inflammation-associated gut microbial ecology instability has 
previously been linked with opportunistic pathogenic infections and colon cancer (34). It is 
noteworthy that the ApcMin/+ microbiome was found to be more variable across untreated 
individuals, when compared to wt littermates, consistent with reduced regulation of the 
microbial population under the influence of the ApcMin/+ mutation. That this observation 
persists despite coprophagia when co-housed with wt litter mates that were reared together 
suggests that the ApcMin/+ mutation plays a role in regulating the composition of the 
microbiome, potentially mediated by cell-based immunity.
In summary, it has been well established in humans and in mice that chronic inflammation 
increases the risk of CRC (21, 23, 25, 31, 36, 37, 45, 46). It is paradoxical, then, that the risk 
for developing CRC is actually lower in countries that have less stringent hygiene practices 
with fewer exposures to potentially pathogenic organisms (40, 41), such as in North 
America. This paradox is explainable using cell transfer assays reveal that “hygienic” CD4+ 
cells may under some circumstances serve to promote carcinogenesis and increase cancer 
risk. This may be due in part to inability of “hygienic” source lymphocytes to suppress 
Th-17 inflammation (16), leading to gut microbiome instability that directly or indirectly 
influences cancer growth. Ultimately, in aging or genetically susceptible hosts this immune 
dysregulation leads to aberrant wound healing and ultimately contributes to cancer growth.
Materials and Methods
Experimental animals—All animals were housed in AAALAC accredited facilities and 
maintained according to protocols approved by the Institutional Animal Care and Use 
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Committee (IACUC) at Massachusetts Institute of Technology. C57BL/6 strain mice of 
defined flora health status were obtained from Taconic Farms (Germantown, NY) to provide 
‘hygienic’ CD4+ cell donors for experimental animals. C57BL/6 background ApcMin/+ mice 
on a C57BL/6J background were originally obtained from Jackson Labs (Bar Harbor, ME), 
then rederived by embryo transfer into Taconic microbial status recipient mice, and then 
bred in-house under standard conditions as (heterozygous X wildtype) crosses to provide 
ApcMin/+ mice and wt littermates of ‘non-hygienic’ status to use as cell recipients. Mice 
were humanely euthanized according to institutional criteria (i.e., poor body condition score, 
large tumor size) or when exhibiting other signs of distress. Experiments were conducted 
using six mice per treatment group as noted throughout the text.
Experimental design—A total of 24 mice were used for these experiments. Twenty 
C57BL/6 wt (N=8) or ApcMin/+ (N=12) littermate mice were included in treatment regimens 
or as experimental controls. Cell recipient and control mice were subdivided into large cages 
with ten mice (six ApcMin/+ and four WT mice) per cage to permit optimal co-housing for 
treatment and microbiome analyses. Fecal specimens were collected individually prior to 
treatment and then again every three weeks until the end of the study. An additional cohort 
of restricted flora C57BL/6 wt mice (N=4) were housed separately in a different animal 
facility and used as donors of ‘hygienic’ CD4+ lymphocytes. Recipient mice were injected 
with CD4+ lymphocytes (N = six ApcMin/+ mice per treatment group), or underwent sham 
injection with media only, at three months of age.
Adoptive transfer of purified CD4+ T cells into recipient mice—CD4+ 
lymphocytes isolated using spleens and mesenteric lymph node from Taconic restricted flora 
wt mice using magnetic beads (Dynal) and then sorted by hi-speed flow cytometry 
(MoFlow2) to obtain purified populations of CD4+ lymphocytes and determined to be ~98% 
pure as previously described elsewhere (16). Anesthetized recipient mice aged three months 
were injected intraperitoneally with 3 ×105 T cells as previously described.
Gut microbiome analyses—We performed on mouse stool high-throughput sequencing 
of the V4 region of the 16S gene using an Ilumina HiSeq platform. After quality filtering, 
we recovered an average of 26,879 reads per sample from 58 samples collected from 18 
animals, including 12 harboring the ApcMin/+ mutation and 6 littermates with a wildtype 
genotype. We clustered these sequences into 1703 operational taxonomic units for further 
analysis as previously described (42). The OTU level analysis for min study utilizes four 
groups of mice, untreated ApcMin/+, untreated wt, ApcMin/+ mice after lymphocyte transfer 
and wt mice after lymphocyte transfer. Each of the 1703 OTUs in our dataset is considered 
as to whether that OTU is enriched in any given treatment group relative to any other 
treatment group, plotted with the log-fold differences for each OTU and group relative to the 
untreated wt group. Red color reflects values below wt and blue reflects values above wt. For 
the p = 0.05 group the range is 4.5 to -4.5 log-fold changes.
Quantitation of intestinal tumors—Intestinal tumors were counted using a 
stereomicroscope at x10 magnification. Location of tumors was determined relative to the 
distance from the pylorus.
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Histopathology and Immunohistochemistry—For histologic evaluation, formalin-
fixed tissues were embedded in paraffin, cut at 4 μm, and stained with hematoxylin and 
eosin or immunohistochemistry (IHC). Polypoid adenomas were classified according to the 
worst preneoplastic lesion they contained. Preneoplastic lesions were classified as low 
(LGD) and high grade dysplasia (HGD) or Carcinoma in situ (CIS) using 
histomorphological criteria that have been earlier described (21, 44). MPO-specific 
immunohistochemistry and quantitative histomorphometry of MPO-positive cells were 
performed as previously described(44).
Statistical analyses—Adenomatous polyp counts and tumor-associated MPO+ 
neutrophils were compared between groups using Mann–Whitney U analysis. The staging of 
polyps according to their most advanced dysplasia/adenoma lesion was compared between 
groups with the Chi-square test. Statistical significance was set at P<0.05. Analyses were 
performed with the Graphpad Prism version 5.0 for windows, GraphPad software, San 
Diego, CA.
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Figure 1. 
The adoptive transfer of “hygienic” CD4+ cells increased ApcMin/+ mouse polypogenesis. 
The y-axis depicts the mean±SEM of intestinal polyp counts. *p<0.05.
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Figure 2. 
The ApcMin/+ mouse microbiomes are more divergent than wt littermates when examining 
the V4 region of the 16S gene using an Ilumina platform. (a) The average pairwise Jensen 
Shannon Divergence (JSD) among ApcMin/+ mice is significantly greater than among wt 
mice or even between ApcMin/+ mice and wt mice. ApcMin/+ mice also deviate from the 
metacommunity significantly more than do wt mice. (b) The microbiome of ApcMin/+ mice 
is dramatically changed after adoptive transfer of ‘hygienic’ CD4+ cells, while wt mice 
experience little change. (c) Display of operational taxonomic unit (OTU)-level events 
Levkovich et al. Page 12
J Anal Oncol. Author manuscript; available in PMC 2015 February 24.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
reveal what is driving high level change shown in bar plots (a & b) above. The plot shows 
the log-fold differences (abundance) of each OTU, with the innermost ring as the untreated 
ApcMin/+, 2nd ring is ApcMin/+ after lymphocyte transfer, 3rd ring is Untreated wt, outermost 
ring is wt mouse microbiome after CD4+ lymphocyte transfer. Values are plotted as color 
intensities red (decreased) or blue (increased) and range from 4.5 to -4.5 log-fold changes, 
when compared with untreated wt mice.
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Figure 3. 
Effects of “hygienic” CD4+ cell transfer on ApcMin/+ mouse polyp histopathology. (a) Side 
by side comparison of typical small intestinal polyps of ApcMin/+ controls (left panel) and 
ApcMin/+ “hygienic” cell recipients (right panel). The most advanced glandular dysplasia/
adenoma lesion found in each polyp is shown bellow in higher magnification. While the 
sham-treated control mouse polyp contains LGD and HGD lesions, the polyp of its age-
matched “hygienic” lymphocyte-treated counterpart contains CIS characterized by increased 
glandular shape and size irregularities, epithelial pseudostratification, cellular atypia, nuclear 
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size and pleomorphism, abnormal mitotic figures and apoptosis. (b) The occurrence of CIS 
is higher in the ApcMin/+ mouse polyps of “hygienic” CD4+ cell recipient mice compared to 
their sham-treated controls and (c) reaches statistical significance. Hematoxylin and Eosin, 
Scale bars: a-upper panel=250 μm; a-lower panel=50 μm. Numbers on the y axis of bar 
graph correspond to the mean±SEM of polyps classified according to their most advanced 
dysplasia/adenoma lesion.
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Figure 4. 
Tumor-associated MPO+ cells in ApcMin/+ mouse polyps. The polyps of “hygienic” cell-
treated mice contain significantly more MPO+ cells (neutrophils) compared to the polyps of 
sham-treated control mice. IHC: DAB chromogen, hematoxylin counterstain. Scale bars=25 
μm. Numbers on the y-axis of bar graph correspond to the mean ± SEM of 
immunohistochemically positive cell counts. *p<0.05.
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